SCHEMBL29395525

CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)C(C)C)[C@@H](C)O

nearest known ligand 0.64

Predicted protein targets (top 7)

	gene	UniProt	supporting neighbours	confidence
▸	VIPR1	P32241	4/20	0.62

▸	GLP1R	P43220	8/20	0.60

▸	ECE1	P42892	1/20	0.60

▸	MUS81	Q96NY9	1/20	0.60

▸	TFPI	P10646	1/20	0.60

▸	VIPR2	P41587	6/20	0.59

▸	OPRL1	P41146	1/20	0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29364983	0.95	TFPI (0.63)	VIPR1GLP1RECE1MUS81TFPI
SCHEMBL29580308	0.94	TFPI (0.68)	VIPR1GLP1RECE1MUS81TFPI
SCHEMBL30012720	0.94	TFPI (0.68)	VIPR1GLP1RECE1MUS81TFPI
SCHEMBL30116705	0.94	TFPI (0.66)	VIPR1GLP1RECE1MUS81TFPI
SCHEMBL29531101	0.94	TFPI (0.69)	VIPR1GLP1RECE1MUS81TFPI
SCHEMBL30880908	0.93	VIPR1 (0.62)	VIPR1GLP1RECE1MUS81TFPI
SCHEMBL29693007	0.92	VIPR1 (0.66)	VIPR1GLP1RECE1MUS81TFPI
SCHEMBL30567756	0.91	VIPR1 (0.72)	VIPR1GLP1RECE1MUS81TFPI
SCHEMBL30658586	0.90	TFPI (0.67)	VIPR1GLP1RECE1MUS81TFPI
SCHEMBL29479830	0.89	VIPR1 (0.69)	VIPR1GLP1RECE1MUS81TFPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-1812062-B1	ANTI-ADDL ANTIBODIES AND USES THEREOF	MERCK SHARP & DOHME (US)	2022-03-09	—	—	EP	claimed
EP-1812062-B1	ANTI-ADDL ANTIBODIES AND USES THEREOF	MERCK SHARP & DOHME (US)	2022-03-09	—	—	EP	disclosed